<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20170404033202N10</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-03-23</date_registration>
      <primary_sponsor>Sabzevar University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the cold normal saline, lidocaine and metoclopramide and the combination of lidocaine and cold normal saline on pain caused by propofol injection</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the cold normal saline, lidocaine and metoclopramide and the combination of lidocaine and cold normal saline on pain caused by propofol injection</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/59665</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients will be selected at random using the most available people for the study. Each person was given a code A or B at random (sheet or envelope) and treatment was performed based on it (group A was intervention and group B was control), Blinding description: In all groups, the amount of pain at 0, 15, and 30 minutes after propofol injection is assessed by another observer who is unaware of the type of drug being injected, based on the VAS, from zero to 10 (zero painless, 10 severe pain).
Outcome assessment is also done by someone who does not know about the groups.</study_design>
      <phase>3</phase>
      <hc_freetext>Reduction of pain caused by propofol in anesthesia.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: The case group consisting of four groups including the first group will inject 10 ml of 0.5% lidocaine at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics. Intervention 2: Intervention group 2: The second group will inject 10 ml of normal serum cold saline 4 degrees at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics. Intervention 3: Intervention group 3: The third group will inject 10 ml of 0.5% lidocaine with 10 cc of normal saline 4 ° at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics. Intervention 4: Intervention group4: The fourth group will be injected with 10 mg metoclerine pyramid at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics. Intervention 5: Control group: The control group will be injected with 10 ml of normal saline at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammad Nematshahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Asadabadi St., Central Organization of Sabzevar University of Medical Sciences</address>
        <city>Sabzwvar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>913885697</zip>
        <telephone>098 51 44229081</telephone>
        <email>9151737407mn@gmail.com</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Nematshahi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Asadabadi St., Central Organization of Sabzevar University of Medical Sciences</address>
        <city>Sabzevar</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9613885697</zip>
        <telephone>+98 51 4422 9081</telephone>
        <email>9151737407mn@gmail.com</email>
        <affiliation>Sabzevar University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Need for general anesthesia with propofol injection
with consent to participate in evaluation
between 18 and 60 years old
ASA class 1 and 2</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>60 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Reluctance to studyPatients
Patients under 20 years and over 60 years
Patients with ASA grade equal to or greater than 3
Patients with advanced heart and lung problems
Sensitivity to any of the drugs used in the study</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: The case group consisting of four groups including the first group will inject 10 ml of 0.5% lidocaine at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics.</i_keyword>
      <i_keyword>Intervention group 2: The second group will inject 10 ml of normal serum cold saline 4 degrees at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics.</i_keyword>
      <i_keyword>Intervention group 3: The third group will inject 10 ml of 0.5% lidocaine with 10 cc of normal saline 4 ° at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics.</i_keyword>
      <i_keyword>Intervention group4: The fourth group will be injected with 10 mg metoclerine pyramid at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics.</i_keyword>
      <i_keyword>Control group: The control group will be injected with 10 ml of normal saline at room temperature. The tourniquet is emptied 15 seconds after the injection. Propofol 50 mg 1% in a volume of 5 ml is then injected into all three groups within 5 seconds. In all groups, the amount of pain at 0 and 10 minutes after propofol injection was assessed by another observer who was unaware of the type of drug being injected, according to Wang Baker. Induction of anesthesia and intubation is performed with 2 mg midazolam, 1.5 / kg fentanyl, the remaining dose of propofol (total dose 2.5 mg / kg and 0.6 mg / kg atracurium. Also, heart rate, mean blood pressure before Drug injection and before induction to evaluate the effect of pain on hemodynamics and immediately after intubation and 5 minutes after intubation to evaluate the effect of lidocaine and propofol on hemodynamics.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Reduction of pain caused by propofol injection after drug injection. Timepoint: Pain rate at 0, 15 and 30 minutes after propofol injection. Method of measurement: Based on VAS from zero to 10.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Sabzevar University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-12</approval_date>
        <contact_name>Sabzevar Medical Sciences</contact_name>
        <contact_address>Sabzevar Medical Sciences Campus Sabzevar Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
